HEMOSTASIS DISORDERS WITH ABNORMAL UTERINE BLEEDING AND THEIR TREATMENT TACTICS
Clinical medicine

HEMOSTASIS DISORDERS WITH ABNORMAL UTERINE BLEEDING AND THEIR TREATMENT TACTICS

Published 2024-08-28

Authors:

I.A. Kachailo
I.Yu. Kuzmina

Abstract:
To determine the specifics of hemostasis disorders in abnormal uterine bleeding, we examined 130 women, of which 110 were female patients who made up the main group. The control group included 20 healthy women without menstrual cycle disorders. It was found that abnormal uterine bleeding in the reproductive age, in the absence of etiopathogenetic treatment, leads to the development of posthemorrhagic anemia. The severity and nature of bleeding are determined by defects in the platelet link system of the hemostasis system that violate the aggregation function of platelets. The study of the overall hemostatic potential, primary hemostasis, and the state of intravascular coagulation in patients with abnormal uterine bleeding using methods for assessing the amount of platelet aggregation allowed us to identify and differentiate disorders in the hemostasis system. The application of modern principles of management of women with abnormal uterine bleeding and the use of fibrinolysis inhibitors allows for an increase in the activity of the blood coagulation system and to stop bleeding for 2–5 days altogether.
Keywords:
abnormal uterine bleeding disorders of the coagulation system overall hemostatic potential fibrinolysis inhibitors
References:
  1. Byrchak IV. Osoblyvosti rehulyatsiyi ahrehatnoho stanu krovi zhinok na tli dysfunktsionalnykh matkovykh krovotech reproduktyvnoho viku. Bukovynskyy medychnyy visnyk, 2014, 18.2 (70). 209–210 [in Ukrainian].
  2. Burka OA, Tutchenko TM, Shumytskyy AV. Rol laboratornykh doslidzhen u diahnostytsi prychyn anomalnykh matkovykh krovotech. Zdorovya zhinky, 2019, 3 (139): 49–52. doi: https://doi.org/10.15574/HW.2019.139.49 [in Ukrainian].
  3. Vovk IB. Osoblyvosti zastosuvannya kombinovanykh oralnykh kontratseptyviv z kontratseptyvnoyu ta likuvalno-profilaktychnoyu metoyu. Medychni aspekty zdorovya zhinky. 2018. №4(117). 5–12. [in Ukrainian].
  4. Pyrohova LV, Chernyshenko TM, Kolesnikova IM, Platonova TM, Bereznytskyy HK, Makohonenko YeM, et al. Riven zahalnoho hemostatychnoho, zhortayuchoho i fibrynolitychnoho potentsialu u plazmi krovi donoriv i khvorykh pry riznykh zakhvoryuvannyakh. Ukr. biokh. zhurn. 2016. Т.88. №2. 56–65. [in Ukrainian].
  5. Tatarchuk TF, Kosey NV, Tutchenko TM. Suchasna diahnostyka ta likuvannya anomalnykh matkovykh krovotech. Reproduktyvna endokrynolohiya. 2018. № 1(3). 74–78. [in Ukrainian].
  6. Bradley LD, Gueye NA. The medical management of abnormal uterine bleeding in reproductive-aged women. Am J Obstet Gynecol. 2016 Jan;214(1):31–44. doi: 10.1016/j.ajog.2015.07.044.
  7. Goldstein SR, Lumsden MA. Abnormal uterine bleeding in perimenopause. Climacteric. 2017 Oct;20(5):414–420. doi: 10.1080/13697137.2017.1358921.
  8. Guasch E, Gilsanz F. Massive obstetric hemorrhage: Current approach to management. Med Intensiva. 2016 Jun-Jul;40(5):298–310. doi: 10.1016/j.medin.2016.02.010.
  9. Lambalk CB, Banga FR, Huirne JA, Toftager M, Pinborg A, Homburg R, et al. GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type. Hum Reprod Update. 2017 Sep 1;23(5):560–579. doi: 10.1093/humupd/dmx017.
  10. Leal CRV, Vannuccini S, Jain V, Dolmans MM, Di Spiezio Sardo A, Al-Hendy A, et al. Abnormal uterine bleeding: The well-known and the hidden face. J Endometr Uterine Disord. 2024 Jun; 6:100071. doi: 10.1016/j.jeud.2024.100071.
  11. Steiner RA, Fink D. Menstruationsstörungen [Abnormal menstrual bleeding]. Praxis (Bern 1994). 2002 Nov 13;91(46):1967–1974. German. doi: 10.1024/0369-8394.91.46.1967.
  12. Wang L, Guan HY, Xia HX, Chen XY, Zhang W. Dydrogesterone treatment for menstrual-cycle regularization in abnormal uterine bleeding – ovulation dysfunction patients. World J Clin Cases. 2020 Aug 6;8(15):3259–3266. doi: 10.12998/wjcc.v8.i15.3259.
  13. Wouk N, Helton M. Abnormal Uterine Bleeding in Premenopausal Women. Am Fam Physician. 2019 Apr 1;99(7):435–443. PMID: 30932448.
Publication:
«World of Medicine and Biology» Vol. 20 No. 89 (2024) , с. 76-81
УДК 618.514-005.1-085